This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Endoscopy of Upper Aerodigestive Tract  • General Rhinology  • Paranasal Sinus Disease  • Surgery  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Neil Bhattacharyya, MD

Arch Otolaryngol Head Neck Surg. 2004;130:975-978.

Objective  To determine if patients undergoing revision endoscopic sinus surgery (ESS) for chronic rhinosinusitis obtain significant symptomatic benefit from surgery.

Design  Prospective controlled clinical trial.

Methods  Adult patients undergoing revision ESS were evaluated preoperatively with a computed tomographic scan and the Rhinosinusitis Symptom Inventory. After the revision ESS, patients were reevaluated with the Rhinosinusitis Symptom Inventory. Data were analyzed for symptom score changes and effect sizes, changes in medication, and economic variables. Improvements in sinonasal symptom scores, medication use, and economic variables were compared with those of a contemporaneous control group of patients undergoing primary ESS and matched for age, sex, and Lund score.

Results  The 21 patients (mean age, 44.8 years) who completed evaluation after revision ESS had a mean follow-up of 12.4 months. Mean preoperative Lund score was 12.6. Large effect sizes indicating significant symptom improvements were noted for nasal obstruction (effect size, –1.9), hyposmia (–0.9), and headache (–0.6), as well as nasal (–1.1) and total symptom domains (–0.9; P<.05 in all cases). Nasal steroid and nonsedating antihistamine use did not decrease significantly after ESS, but oral antibiotic use showed a downward trend (net change, – 2.9 wk/y; P = .23). Improvements in clinical symptoms were statistically similar to corresponding improvements in the matched cohort of patients undergoing primary ESS.

Conclusions  The symptomatic relief that revision ESS can provide for patients with refractory chronic rhinosinusitis is similar to that following a primary ESS. However, many patients undergoing revision ESS require continued intense medical management of their chronic rhinosinusitis.

From the Department of Otology & Laryngology, Harvard Medical School, and the Division of Otolaryngology, Brigham and Women's Hospital, Boston, Mass. The author has no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sinus Surgery in Patients With Previously Repaired Cerebrospinal Fluid Leaks
Reh et al.
Arch Otolaryngol Head Neck Surg 2008;134:1187-1190.
ABSTRACT | FULL TEXT  

The nose and sex: the nasogenital reflex revisited
Chester
JRSM 2007;100:489-490.
FULL TEXT